Close

Covidien Completes Transition to New and Improved Magellan Safety Needle

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

WHO Supplies Medical Equipment for Post-Marburg...

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK...

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences...

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized...

The Human Medicines Regulations 2025, which came into force...
Covidien, a leading global provider of healthcare products, confirmed the immediate availability of its new and improved Magellan(TM) Safety Hypodermic Needle. The modified design, which is now shipping to all customers, is in stock and available at all Covidien distribution centers in the United States. Beginning today, the previous needle model is no longer being produced or sold.

Covidien, a leading global provider of healthcare products, confirmed the immediate availability of its new and improved Magellan(TM) Safety Hypodermic Needle. The modified design, which is now shipping to all customers, is in stock and available at all Covidien distribution centers in the United States. Beginning today, the previous needle model is no longer being produced or sold.

Jeff Hunt, President, Patient Care and Safety Products, Covidien said, The feedback on the updated Magellan Safety Hypodermic Needle has been extremely positive. We have increased capacity to allow for a smooth transition with our existing customers, and this expansion has enabled us to meet the growing demands of the safety needle market.

The conversion to the improved Magellan Safety Hypodermic Needle has been ongoing since October, and Covidien has worked closely with its existing customers and distribution partners to ensure a smooth transition and uninterrupted supply.

Latest stories

Related stories

WHO Supplies Medical Equipment for Post-Marburg Virus Heal

In a recent move, the World Health Organization has...

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back